Denali Advisors LLC
- SEC CIK
- 0001142941
- Latest filing
- Aug 10, 2026
GTHX holding history
G1 Therapeutics, Inc. in every 13F filed by Denali Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GTHX overviewAll 13F holders of GTHXFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −86,100−100.0% | Sold out | Holders |
| Q1 2024 | 86,100 | $372.0K | 0.1% | −35,700−29.3% | Reduced | Holders |
| Q4 2023 | 121,800 | $371.5K | 0.1% | −27,000−18.1% | Reduced | Holders |
| Q3 2023 | 148,800 | $214.3K | 0.1% | +81,700+121.8% | Added | Holders |
| Q2 2023 | 67,100 | $167.1K | 0.1% | +67,100 | New | Holders |